• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与2型糖尿病、心血管疾病和非酒精性脂肪性肝病相关的PPAR2中有害脯氨酸12丙氨酸单核苷酸多态性的分子动力学模拟和主成分动力学

Molecular Dynamics Simulation and Essential Dynamics of Deleterious Proline 12 Alanine Single-Nucleotide Polymorphism in PPAR2 Associated with Type 2 Diabetes, Cardiovascular Disease, and Nonalcoholic Fatty Liver Disease.

作者信息

Taghvaei Somayye, Saremi Leila

机构信息

Department of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran.

Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.

出版信息

PPAR Res. 2022 May 2;2022:3833668. doi: 10.1155/2022/3833668. eCollection 2022.

DOI:10.1155/2022/3833668
PMID:35547362
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9085344/
Abstract

. Peroxisome proliferator-activated receptor- () gene is located at 3p25 position. PPAR functions as the master regulator of glucose homeostasis and lipoprotein metabolism, and recent studies have reported that it is involved in various metabolic diseases such as diabetes mellitus, hyperlipidemia, coronary artery disease (CAD), and nonalcoholic fatty liver disease (NAFLD). PPAR1 and PPAR2 are necessary for the development of adipose tissue and insulin sensitivity regulation. But PPAR2 is the isoform that was controlled in response to nutrient intake and obesity. . In this study, we used computational techniques to show the impact of Pro12Ala polymorphism on PPAR2. The 3-D structure of PPAR2 was modeled using I-TASSER server. The modeled structure was validated with the ZLab server, and the mutation was created with SPDB viewer. Stability prediction tools were used. Molecular dynamics simulation (MDS) was used to understand the structural and functional behavior of the wild type and mutant. Essential dynamics was also applied. . Stability prediction tools were showed that this mutation has a destabilizing effect on the PPAR2 structure. The RMSD, RMSF, Rg, SASA, and DSSP were in line with H-bond results that showed less flexibility in the mutant structure. Essential dynamics was used to verify MDS results. Pro12Ala polymorphism leads to rigidity of the PPAR2 protein and might disturb the conformational changes and interactions of PPAR2 and results in type 2 diabetes mellitus (T2DM), CAD, and NAFLD. This study can help scientists to develop a drug therapy against these diseases.

摘要

过氧化物酶体增殖物激活受体-()基因位于3p25位置。PPAR作为葡萄糖稳态和脂蛋白代谢的主要调节因子,最近的研究报道它参与了多种代谢性疾病,如糖尿病、高脂血症、冠状动脉疾病(CAD)和非酒精性脂肪性肝病(NAFLD)。PPAR1和PPAR2对于脂肪组织的发育和胰岛素敏感性调节是必需的。但PPAR2是受营养摄入和肥胖影响而被调控的异构体。在本研究中,我们使用计算技术来展示Pro12Ala多态性对PPAR2的影响。使用I-TASSER服务器对PPAR2的三维结构进行建模。使用ZLab服务器对建模结构进行验证,并使用SPDB查看器创建突变。使用稳定性预测工具。分子动力学模拟(MDS)用于了解野生型和突变体的结构和功能行为。还应用了主成分动力学。稳定性预测工具表明,这种突变对PPAR2结构具有去稳定作用。均方根偏差(RMSD)、均方根波动(RMSF)、回旋半径(Rg)、溶剂可及表面积(SASA)和二级结构预测(DSSP)与氢键结果一致,表明突变体结构的灵活性较低。主成分动力学用于验证MDS结果。Pro12Ala多态性导致PPAR2蛋白刚性增加,可能会干扰PPAR2的构象变化和相互作用,从而导致2型糖尿病(T2DM)、CAD和NAFLD。本研究有助于科学家开发针对这些疾病的药物治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9609/9085344/7a84579a0f20/PPAR2022-3833668.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9609/9085344/3387bde5d0b6/PPAR2022-3833668.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9609/9085344/cc98f394b29e/PPAR2022-3833668.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9609/9085344/7b134aeb9ac2/PPAR2022-3833668.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9609/9085344/29be64f525cd/PPAR2022-3833668.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9609/9085344/cb76113f4992/PPAR2022-3833668.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9609/9085344/7a84579a0f20/PPAR2022-3833668.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9609/9085344/3387bde5d0b6/PPAR2022-3833668.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9609/9085344/cc98f394b29e/PPAR2022-3833668.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9609/9085344/7b134aeb9ac2/PPAR2022-3833668.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9609/9085344/29be64f525cd/PPAR2022-3833668.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9609/9085344/cb76113f4992/PPAR2022-3833668.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9609/9085344/7a84579a0f20/PPAR2022-3833668.006.jpg

相似文献

1
Molecular Dynamics Simulation and Essential Dynamics of Deleterious Proline 12 Alanine Single-Nucleotide Polymorphism in PPAR2 Associated with Type 2 Diabetes, Cardiovascular Disease, and Nonalcoholic Fatty Liver Disease.与2型糖尿病、心血管疾病和非酒精性脂肪性肝病相关的PPAR2中有害脯氨酸12丙氨酸单核苷酸多态性的分子动力学模拟和主成分动力学
PPAR Res. 2022 May 2;2022:3833668. doi: 10.1155/2022/3833668. eCollection 2022.
2
Computational Analysis of Gly482Ser Single-Nucleotide Polymorphism in PPARGC1A Gene Associated with CAD, NAFLD, T2DM, Obesity, Hypertension, and Metabolic Diseases.PPARGC1A基因中与冠心病、非酒精性脂肪性肝病、2型糖尿病、肥胖症、高血压及代谢性疾病相关的Gly482Ser单核苷酸多态性的计算分析
PPAR Res. 2021 Aug 5;2021:5544233. doi: 10.1155/2021/5544233. eCollection 2021.
3
Effects of Pro12Ala polymorphism in peroxisome proliferator-activated receptor-γ2 gene on metabolic syndrome risk: a meta-analysis.过氧化物酶体增殖物激活受体-γ2 基因 Pro12Ala 多态性对代谢综合征风险的影响:荟萃分析。
Gene. 2014 Feb 1;535(1):79-87. doi: 10.1016/j.gene.2013.07.087. Epub 2013 Sep 5.
4
PPARγ2 polymorphism and human health.过氧化物酶体增殖物激活受体 γ2 多态性与人类健康。
PPAR Res. 2009;2009:849538. doi: 10.1155/2009/849538. Epub 2009 Apr 16.
5
Effect of the Pro12Ala polymorphism in the peroxisome proliferator-activated receptor (PPAR) gamma2 gene on the expression of PPARgamma target genes in adipose tissue of massively obese subjects.过氧化物酶体增殖物激活受体(PPAR)γ2基因中Pro12Ala多态性对极度肥胖受试者脂肪组织中PPARγ靶基因表达的影响。
J Clin Endocrinol Metab. 2003 Apr;88(4):1717-22. doi: 10.1210/jc.2002-020603.
6
Relationships of PPARgamma and PPARgamma2 mRNA levels to obesity, diabetes and hyperinsulinaemia in rhesus monkeys.恒河猴中PPARγ和PPARγ2 mRNA水平与肥胖、糖尿病及高胰岛素血症的关系
Int J Obes Relat Metab Disord. 1998 Oct;22(10):1000-10. doi: 10.1038/sj.ijo.0800718.
7
ASSOCIATION BETWEEN PRO12ALa POLYMORPHISM OF PPARγ2 GENE AND CORONARY ARTERY DISEASE IN IRANIAN POPULATION WITH TYPE TWO DIABETES MELLITUS.伊朗2型糖尿病患者中PPARγ2基因Pro12Ala多态性与冠状动脉疾病的关联
Acta Endocrinol (Buchar). 2022 Apr-Jun;18(2):139-144. doi: 10.4183/aeb.2022.139.
8
Peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms in nonalcoholic fatty liver disease: a study in Brazilian patients.过氧化物酶体增殖物激活受体α和γ2 多态性与非酒精性脂肪性肝病:巴西患者的研究。
Gene. 2013 Oct 25;529(2):326-31. doi: 10.1016/j.gene.2013.06.091. Epub 2013 Jul 24.
9
The association of Pro12Ala polymorphism in PPARgamma2 with lower carotid artery IMT in Japanese.日本人群中PPARγ2基因Pro12Ala多态性与较低颈动脉内膜中层厚度的关联。
Diabetes Res Clin Pract. 2003 Oct;62(1):55-9. doi: 10.1016/s0168-8227(03)00161-x.
10
Pro12Ala polymorphism of the peroxisome proliferator-activated receptor γ2 in patients with fatty liver diseases.过氧化物酶体增殖物激活受体 γ2 Pro12Ala 多态性与脂肪性肝病。
World J Gastroenterol. 2010 Dec 14;16(46):5830-7. doi: 10.3748/wjg.v16.i46.5830.

引用本文的文献

1
Molecular docking and simulation analysis of nimbolide with poly-galacturonase from : Managing black mold disease for .印楝素与来自……的多聚半乳糖醛酸酶的分子对接及模拟分析:用于……的黑霉病防治
Bioinformation. 2025 May 31;21(5):1050-1056. doi: 10.6026/973206300211050. eCollection 2025.
2
Emodin, a rising star in the treatment of glycolipid metabolism disorders: a preclinical systematic review and meta-analysis.大黄素——治疗糖脂代谢紊乱的后起之秀:一项临床前系统评价与荟萃分析
PeerJ. 2025 May 15;13:e19221. doi: 10.7717/peerj.19221. eCollection 2025.
3
Repositioning of anti-infective compounds against monkeypox virus core cysteine proteinase: a molecular dynamics study.

本文引用的文献

1
Computational Analysis of Gly482Ser Single-Nucleotide Polymorphism in PPARGC1A Gene Associated with CAD, NAFLD, T2DM, Obesity, Hypertension, and Metabolic Diseases.PPARGC1A基因中与冠心病、非酒精性脂肪性肝病、2型糖尿病、肥胖症、高血压及代谢性疾病相关的Gly482Ser单核苷酸多态性的计算分析
PPAR Res. 2021 Aug 5;2021:5544233. doi: 10.1155/2021/5544233. eCollection 2021.
2
Identification of selective cyclin-dependent kinase 2 inhibitor from the library of pyrrolone-fused benzosuberene compounds: an in silico exploration.从吡咯烷酮稠合苯并[ b ]色烯化合物库中鉴定选择性细胞周期蛋白依赖性激酶 2 抑制剂:一种计算机探索。
J Biomol Struct Dyn. 2022 Oct;40(17):7693-7701. doi: 10.1080/07391102.2021.1900918. Epub 2021 Mar 22.
3
抗猴痘病毒核心半胱氨酸蛋白酶抗感染化合物的重新定位:一项分子动力学研究
Mol Divers. 2024 Dec;28(6):4113-4135. doi: 10.1007/s11030-023-10802-8. Epub 2024 Apr 23.
4
Computational study of SENP1 in cancer by novel natural compounds and ZINC database screening.通过新型天然化合物和ZINC数据库筛选对SENP1在癌症中的计算研究。
Front Pharmacol. 2023 Jul 12;14:1144632. doi: 10.3389/fphar.2023.1144632. eCollection 2023.
Identification of novel anti-cancer agents, applying method for SENP1 protease inhibition.
应用 SENP1 蛋白酶抑制方法鉴定新型抗癌药物。
J Biomol Struct Dyn. 2022 Sep;40(14):6228-6242. doi: 10.1080/07391102.2021.1880480. Epub 2021 Feb 3.
4
Investigating mutations at the hotspot position of the ERBB2 and screening for the novel lead compound to treat breast cancer - a computational approach.研究 ERBB2 热点位置的突变并筛选新型先导化合物治疗乳腺癌 - 一种计算方法。
Adv Protein Chem Struct Biol. 2021;123:49-71. doi: 10.1016/bs.apcsb.2020.10.001. Epub 2020 Dec 4.
5
Himalayan bioactive molecules as potential entry inhibitors for the human immunodeficiency virus.喜马拉雅生物活性分子作为人类免疫缺陷病毒的潜在进入抑制剂。
Food Chem. 2021 Jun 15;347:128932. doi: 10.1016/j.foodchem.2020.128932. Epub 2020 Dec 27.
6
Deciphering the Role of Filamin B Calponin-Homology Domain in Causing the Larsen Syndrome, Boomerang Dysplasia, and Atelosteogenesis Type I Spectrum Disorders via a Computational Approach.通过计算方法解析细丝蛋白 B 卷曲螺旋结构域在导致 Larsen 综合征、回旋镖样肢畸形和 I 型成骨发育不全谱障碍中的作用。
Molecules. 2020 Nov 26;25(23):5543. doi: 10.3390/molecules25235543.
7
Discovery and in silico evaluation of aminoarylbenzosuberene molecules as novel checkpoint kinase 1 inhibitor determinants.氨基芳基苯并环庚烯分子作为新型检查点激酶1抑制剂决定因素的发现及计算机模拟评估
Genomics. 2021 Jan;113(1 Pt 2):707-715. doi: 10.1016/j.ygeno.2020.10.001. Epub 2020 Oct 13.
8
Comprehensive in silico screening and molecular dynamics studies of missense mutations in Sjogren-Larsson syndrome associated with the ALDH3A2 gene.基于 ALDH3A2 基因的 Sjogren-Larsson 综合征相关错义突变的综合计算机筛选和分子动力学研究。
Adv Protein Chem Struct Biol. 2020;120:349-377. doi: 10.1016/bs.apcsb.2019.11.004. Epub 2020 Feb 4.
9
An extensive computational approach to analyze and characterize the functional mutations in the galactose-1-phosphate uridyl transferase (GALT) protein responsible for classical galactosemia.一种广泛的计算方法,用于分析和表征导致经典半乳糖血症的1-磷酸半乳糖尿苷酰转移酶(GALT)蛋白中的功能性突变。
Comput Biol Med. 2020 Feb;117:103583. doi: 10.1016/j.compbiomed.2019.103583. Epub 2019 Dec 13.
10
Identification of naturally originated molecules as γ-aminobutyric acid receptor antagonist.鉴定天然产物为γ-氨基丁酸受体拮抗剂。
J Biomol Struct Dyn. 2021 Feb;39(3):911-922. doi: 10.1080/07391102.2020.1720818. Epub 2020 Feb 12.